Aryabhatta Sadhu: Evidence-Based Restrictive Transfusion and Patient Blood Management
Aryabhatta Sadhu, Attending Consultant and Head of Transfusion Medicine at Fortis Hospital Shalimar Bagh, New Delhi, shared a post on LinkedIn:
“One of the most deeply entrenched assumptions in clinical practice is that more transfusion equates to better patient care.
The evidence does not support that conclusion.
Over the past two decades, landmark studies including TRICC, FOCUS, and TRISS, together with contemporary AABB recommendations, have consistently demonstrated that liberal transfusion strategies often fail to improve outcomes in stable patients while increasing exposure to transfusion-related complications and resource utilization.
Modern transfusion medicine extends far beyond the administration of blood components. It is a discipline centered on clinical decision-making, patient safety, and evidence-based hemotherapy.
The evolution has been clear:
- From product-focused transfusion to patient-centered care
- From empirical component use to goal-directed therapy
- From laboratory values alone to clinically meaningful outcomes
- From reactive transfusion practices to Patient Blood Management (PBM)
Every transfusion should be guided by a fundamental question:
What specific physiological deficit is being corrected, and is transfusion the most appropriate intervention to address it?
The objective is not to transfuse less.
The objective is to transfuse appropriately.”

Stay updates with Hemostasis Today.
-
Nov 15, 2026, 16:29Jean-Jacques Kiladjian: 20 Years of Interferon-Alpha Research in Myeloproliferative Neoplasms
-
Nov 15, 2026, 16:21Sukanto Paul: Why Platelet Transfusion Is Generally Avoided in TTP
-
Nov 15, 2026, 16:14Ahmad G. Alzahrani: Major Bleeding and Anticoagulant Reversal
-
Nov 15, 2026, 16:05Sabine Eichinger: Is Recurrence Risk After Provoked VTE Really Low?
-
Nov 15, 2026, 15:53Nicolas Schommer: The Seed and Soil Hypothesis of NET-Mediated Inflammation
-
Nov 15, 2026, 15:36Giovanni Merlino: Targeting LDL-C to Prevent Recurrent Stroke
-
Nov 15, 2026, 15:33Riitta Lassila: From Helsinki to ISTH 2027 Advancing Thrombosis Research
-
Nov 15, 2026, 15:30Andreas Calatzis: Can Protein C and Plasma Overcome Fibrinolysis Resistance in Sepsis?
-
Nov 15, 2026, 15:25Hussnain Javaid: Thalassaemia 2026 New Therapies Transforming UK Practice